Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.4K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Era of Large-Scale Data in Biological Sciences.

Advances in experimental medicine and biology·2026
Same author

Microarrays and the Dawn of Omics Data Analysis.

Advances in experimental medicine and biology·2026
Same author

Advances in Massive Parallel Sequencing: From Genomics to Spatial Transcriptomics.

Advances in experimental medicine and biology·2026
Same author

TCRcloud: a global visualization tool for T-cell and B-cell receptor transcripts.

Journal of translational medicine·2026
Same author

The Challenge of Lyme Borreliosis: Knowledge, Attitudes, and Practices in France.

Biology·2025
Same author

Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018-2024).

Pathogens (Basel, Switzerland)·2025
Same journal

Tissue MicroRNAs in Arrhythmogenic Cardiomyopathy: A Systematic Review of Studies in Human Myocardium and Animal Models with Implications for Post-Mortem Molecular Diagnostics.

Genes·2026
Same journal

Genetic Variants and Dental Caries Susceptibility: An Umbrella Review and Multilevel Meta-Analysis.

Genes·2026
Same journal

Generative AI and Language Models in Human Genetics and Health: From Variant Interpretation to Clinical Decision Support.

Genes·2026
Same journal

Familial White-Sutton Syndrome Caused by a Pathogenic POGZ p.Arg508* Variant: Intrafamilial Variability from Childhood to Adulthood.

Genes·2026
Same journal

Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia.

Genes·2026
Same journal

THBS1 as a Key Regulator of Myoblasts: Validation of Its Inhibitory Roles in Skeletal Muscle Development.

Genes·2026
See all related articles

Related Experiment Video

Updated: Oct 2, 2025

Isolation, Transfection, and Culture of Primary Human Monocytes
09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

13.7K

Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection.

Mark S Gibson1, Cláudia Noronha-Estima1, Margarida Gama-Carvalho1

  • 1BioISI-Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, 1749-016 Lisboa, Portugal.

Genes
|February 25, 2022
PubMed
Summary
This summary is machine-generated.

Reprogramming cellular metabolism with microRNAs (miRNAs) shows promise for cancer therapy. This approach may also help restrict HIV replication by targeting infected immune cells.

Keywords:
HIVcancerimmunometabolismmetabolismmicroRNAstherapy

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.8K

Related Experiment Videos

Last Updated: Oct 2, 2025

Isolation, Transfection, and Culture of Primary Human Monocytes
09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

13.7K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.8K

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular metabolism and play roles in cancer progression.
  • Cancer cells exhibit significant metabolic alterations, and immunometabolism research reveals unique metabolic signatures in immune cells.
  • CD4+ T-cell susceptibility to HIV infection is linked to their metabolic activity, sharing similarities with cancer cell metabolism.

Purpose of the Study:

  • To review the potential of miRNA modulation for metabolic reprogramming in cancer therapy.
  • To explore the application of miRNA-based metabolic reprogramming for restricting HIV replication and eliminating infected cells.

Main Methods:

  • Literature review of studies on miRNA function in cellular metabolism, cancer, and HIV infection.
  • Analysis of the link between metabolic changes in cancer and HIV-infected cells.
  • Discussion of therapeutic strategies involving miRNA modulation.

Main Results:

  • miRNA-mediated metabolic reprogramming is a viable strategy for cancer treatment.
  • Metabolic similarities between cancer and HIV-infected cells suggest a shared therapeutic vulnerability.
  • Targeting cellular metabolism via miRNAs could offer a novel approach to combat HIV.

Conclusions:

  • miRNA-based metabolic reprogramming holds significant therapeutic potential for both cancer and HIV.
  • Further research into immunometabolism and miRNA regulation is crucial for developing these novel therapies.